Company Filing History:
Years Active: 1991-2025
Title: Innovations of Inventor Gilles Etienne
Introduction
Gilles Etienne is a notable inventor based in Toulouse, France. He has made significant contributions to the field of biotechnology, particularly in the development of antigenic tripeptides. With a total of 5 patents to his name, his work has implications for detecting infections in animals.
Latest Patents
One of his latest patents is focused on antigenic tripeptides derived from subsp. S-type strains. This invention is directed to an isolated synthetic tripeptide of formula H-D-Phe-N-Methyl-L-Val-L-Ala-OMe (SEQ ID NO: 1), or a derivative thereof. The corresponding lipotripeptides are specific to subsp. (Map) S-type strain, along with their derivatives and conjugates. The invention also addresses the use of these antigens in various methods and tests for detecting Map infection, particularly by identifying humoral and cell-mediated responses in infected animals. Additionally, it includes a genetic signature of Map and a mass spectrometry and NMR spectroscopy signature for detecting Map presence or infection.
Career Highlights
Gilles Etienne has worked with prestigious organizations, including Institut Pasteur and the United States of America, as represented by the Secretary of Agriculture. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Throughout his career, Gilles has collaborated with notable individuals such as John P. Bannantine and Sylvie Bay. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Gilles Etienne's innovative work in the field of biotechnology, particularly in the development of antigenic tripeptides, showcases his dedication to advancing scientific knowledge. His contributions are vital for improving methods of detecting infections in animals, highlighting the importance of his inventions in the scientific community.